Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia

Among the therapeutic options for achalasia are pneumatic dilatation (PD), an appropriate long-term therapy, and botulinum toxin injection (BT) that is a relatively short-term therapy. This study aimed to compare therapeutic effect of repetitive pneumatic dilation with a combined method (botulinum t...

Full description

Bibliographic Details
Main Authors: Alireza Bakhshipour, Romina Rabbani, Shapoor Shirani, Hosein ASL Soleimani, Javad Mikaeli
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-03-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15255.pdf&manuscript_id=15255
_version_ 1818908027103739904
author Alireza Bakhshipour
Romina Rabbani
Shapoor Shirani
Hosein ASL Soleimani
Javad Mikaeli
author_facet Alireza Bakhshipour
Romina Rabbani
Shapoor Shirani
Hosein ASL Soleimani
Javad Mikaeli
author_sort Alireza Bakhshipour
collection DOAJ
description Among the therapeutic options for achalasia are pneumatic dilatation (PD), an appropriate long-term therapy, and botulinum toxin injection (BT) that is a relatively short-term therapy. This study aimed to compare therapeutic effect of repetitive pneumatic dilation with a combined method (botulinum toxin injection and pneumatic dilation) in a group of achalasia patients who are low responder to two initial pneumatic dilations. Thirty- four patients with documented primary achalasia that had low response to two times PD (<50% decrease in symptom score and barium height at 5 minute in timed esophagogram after 3month of late PD) were randomized to receive pneumatic dilation (n=18) or botulinum toxin injection and pneumatic dilation by four weeks interval (n=16), PD and BT+PD groups respectively. Symptom scores were evaluated before and at 1, 6 and 12 months after treatment. Clinical remission was defined as a decrease in symptom score ≥ 50% of baseline. There were no significant differences between the two groups in gender, age and achalasia type. Remission rate of patients in BT-PD group in comparison with PD group were 87.5% vs. 67.1% (P = 0.7), 87.5% vs. 61.1% (P = 0.59) and 87.5% vs. 55.5% (P = 0.53) at 1, 6 and 12 months respectively .There were no major complications in either group. The mean symptom score decreased by 62.71% in the BT-PD group (P < 0.002) and 50.77% in the PD group (P < 0.01) at the end of the first year. Despite a better response rate in BT+PD group, a difference was not statistically significant. A difference may be meaningful if a large numbers of patients are included in the study.
first_indexed 2024-12-19T22:04:29Z
format Article
id doaj.art-35a5222fa881487e9d5ad05027c6ef1b
institution Directory Open Access Journal
issn 0044-6025
language English
last_indexed 2024-12-19T22:04:29Z
publishDate 2010-03-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-35a5222fa881487e9d5ad05027c6ef1b2022-12-21T20:04:04ZengTehran University of Medical SciencesActa Medica Iranica0044-60252010-03-01482107110Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of AchalasiaAlireza BakhshipourRomina RabbaniShapoor ShiraniHosein ASL SoleimaniJavad MikaeliAmong the therapeutic options for achalasia are pneumatic dilatation (PD), an appropriate long-term therapy, and botulinum toxin injection (BT) that is a relatively short-term therapy. This study aimed to compare therapeutic effect of repetitive pneumatic dilation with a combined method (botulinum toxin injection and pneumatic dilation) in a group of achalasia patients who are low responder to two initial pneumatic dilations. Thirty- four patients with documented primary achalasia that had low response to two times PD (<50% decrease in symptom score and barium height at 5 minute in timed esophagogram after 3month of late PD) were randomized to receive pneumatic dilation (n=18) or botulinum toxin injection and pneumatic dilation by four weeks interval (n=16), PD and BT+PD groups respectively. Symptom scores were evaluated before and at 1, 6 and 12 months after treatment. Clinical remission was defined as a decrease in symptom score ≥ 50% of baseline. There were no significant differences between the two groups in gender, age and achalasia type. Remission rate of patients in BT-PD group in comparison with PD group were 87.5% vs. 67.1% (P = 0.7), 87.5% vs. 61.1% (P = 0.59) and 87.5% vs. 55.5% (P = 0.53) at 1, 6 and 12 months respectively .There were no major complications in either group. The mean symptom score decreased by 62.71% in the BT-PD group (P < 0.002) and 50.77% in the PD group (P < 0.01) at the end of the first year. Despite a better response rate in BT+PD group, a difference was not statistically significant. A difference may be meaningful if a large numbers of patients are included in the study.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15255.pdf&manuscript_id=15255Balloon dilationbotulinum toxinsesophageal achalasia
spellingShingle Alireza Bakhshipour
Romina Rabbani
Shapoor Shirani
Hosein ASL Soleimani
Javad Mikaeli
Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
Acta Medica Iranica
Balloon dilation
botulinum toxins
esophageal achalasia
title Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
title_full Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
title_fullStr Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
title_full_unstemmed Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
title_short Comparison of Pneumatic Dilation with Pneumatic Dilation Plus Botulinum Toxin for Treatment of Achalasia
title_sort comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia
topic Balloon dilation
botulinum toxins
esophageal achalasia
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15255.pdf&manuscript_id=15255
work_keys_str_mv AT alirezabakhshipour comparisonofpneumaticdilationwithpneumaticdilationplusbotulinumtoxinfortreatmentofachalasia
AT rominarabbani comparisonofpneumaticdilationwithpneumaticdilationplusbotulinumtoxinfortreatmentofachalasia
AT shapoorshirani comparisonofpneumaticdilationwithpneumaticdilationplusbotulinumtoxinfortreatmentofachalasia
AT hoseinaslsoleimani comparisonofpneumaticdilationwithpneumaticdilationplusbotulinumtoxinfortreatmentofachalasia
AT javadmikaeli comparisonofpneumaticdilationwithpneumaticdilationplusbotulinumtoxinfortreatmentofachalasia